Treatment of advanced mycosis fungoides by allogeneic stem-cell transplantation with a nonmyeloablative regimen - PubMed (original) (raw)

Case Reports

doi: 10.1038/sj.bmt.1703872.

A Ibatici, E Berti, P Morandi, E Longhi, L Venegoni, M Corbellino, C Annaloro, L Robbiolo, A Della Volpe, E Alessi, G Lambertenghi Deliliers

Affiliations

Case Reports

Treatment of advanced mycosis fungoides by allogeneic stem-cell transplantation with a nonmyeloablative regimen

D Soligo et al. Bone Marrow Transplant. 2003 Apr.

Abstract

Given the poor prognosis of patients with advanced cutaneous T-cell lymphoma and the high transplant-related mortality associated with conventional allogeneic bone marrow transplantation, we performed nonmyeloablative transplantation of allogeneic stem cells (ASCT) from HLA-identical siblings in three patients with this disease. All patients achieved full donor engraftment, clearance of clonal T cells leading to durable complete remissions but experienced high incidence of infections, which proved fatal in one case. These results suggest that nonmyeloablative ASCT is a novel and potentially curative therapy for patients with advanced T-cell lymphomas who have a histocompatible sibling.

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources